Melissa Radcliffe
Psychiatric/Mental Health · Layton, UTNPI 1992356240
Payments from drug & device makers
Across 94 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$630
- Indivior Inc.$160
- Johnson & Johnson$116
- Otsuka America Pharmaceutical, Inc.$112
- AstraZeneca$69
- Alkermes, Inc.$62
- plus $358 from 14 others
What the payments were for
- Food & beverage$1,507100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $630 |
| Indivior Inc. | 9 | $160 |
| Johnson & Johnson | 7 | $116 |
| Otsuka America Pharmaceutical, Inc. | 6 | $112 |
| AstraZeneca | 5 | $69 |
| Alkermes, Inc. | 3 | $62 |
| Axsome Therapeutics, Inc. | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Baxter Healthcare | 2 | $34 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $32 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| Lilly USA, LLC | 2 | $26 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
| USWM, LLC | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Virtus Pharmaceuticals LLC | 1 | $15 |
How this compares
$1,507 in reported general payments places this provider in the 70th percentile of 393 psychiatric/mental health providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 22 | $27,425 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $630 | $27,42522 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 393 psychiatric/mental health providers in Utah.
Other psychiatric/mental health in Layton
- Bret HafenLayton$381K
- Colby JamesLayton$8K
- Craig FrancisLayton$7K
- Benjamin SaxeyLayton$7K
- Heather KrambuleLayton$6K
- Sherrie SmithLayton$4K
- Marie HurstLayton$4K
- Colin RileyLayton$3K
- Mitzy StewartLayton$3K
- Alberto SouzaSaint George$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.